1. Home
  2. MGYR vs GANX Comparison

MGYR vs GANX Comparison

Compare MGYR & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magyar Bancorp Inc.

MGYR

Magyar Bancorp Inc.

HOLD

Current Price

$17.66

Market Cap

114.1M

Sector

Finance

ML Signal

HOLD

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$2.13

Market Cap

78.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGYR
GANX
Founded
1922
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.1M
78.2M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
MGYR
GANX
Price
$17.66
$2.13
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
3.1K
552.8K
Earning Date
05-04-2026
05-13-2026
Dividend Yield
2.25%
N/A
EPS Growth
26.83
31.46
EPS
0.50
N/A
Revenue
N/A
$55,180.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$35.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.75
$1.41
52 Week High
$20.00
$4.34

Technical Indicators

Market Signals
Indicator
MGYR
GANX
Relative Strength Index (RSI) 51.99 53.96
Support Level $16.83 $1.55
Resistance Level $17.91 $2.40
Average True Range (ATR) 0.41 0.14
MACD 0.05 0.05
Stochastic Oscillator 67.62 84.46

Price Performance

Historical Comparison
MGYR
GANX

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Share on Social Networks: